HLA-B*5901 is strongly associated with methazolamide-induced Stevens-Johnson syndrome/toxic epidermal necrolysis

Pharmacogenomics

Volumn 11, Issue 6, 2010, Pages 879-884

  Kim, Sae Hoon ^a,b   Kim, Myunghwa ^c   Lee, Kyung Wha ^d   Kim, Sang Heon ^e   Kang, Hye Ryun ^a   Park, Heung Woo ^a   Jee, Young Koo ^f  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

^c Dankook University College of Medicine   (South Korea)

^d Hallym University   (South Korea)

^e Hanyang University College of Medicine   (South Korea)

^f NONE

Author keywords

Carbonic anhydrase inhibitor; Human leukocyte antigen; Methazolamide; Stevens Johnson syndrome; Toxic epidermal necrolysis

Indexed keywords

HLA A ANTIGEN; HLA ANTIGEN CLASS 1; HLA B ANTIGEN; HLA C ANTIGEN; METHAZOLAMIDE;

ADULT; ARTICLE; CHORIORETINITIS; CHORIORETINOPATHY; CLINICAL ARTICLE; DRUG INDICATION; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE IDENTIFICATION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENOTYPE; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE ABNORMALITY; MALE; PHENOTYPE; SEROTYPE; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS; TREATMENT DURATION; ALLELE; CHEMICALLY INDUCED DISORDER; GENETICS; IMMUNOLOGY; MIDDLE AGED; SOUTH KOREA;

ADULT; ALLELES; EPIDERMAL NECROLYSIS, TOXIC; FEMALE; GENOTYPE; HLA-B ANTIGENS; HUMANS; MALE; METHAZOLAMIDE; MIDDLE AGED; REPUBLIC OF KOREA; STEVENS-JOHNSON SYNDROME;

EID: 77952937737     PISSN: 14622416     EISSN: 17448042     Source Type: Journal    
DOI: 10.2217/pgs.10.54     Document Type: Article

References (31)

1. Flach AJ, Smith RE, Flaunfelder FT: Stevens-Johnson syndrome associated with methazolamide treatment reported in two Japanese-American women. Ophthalmology 102(11), 1677-1680 (1995).
2. Shirato S, Kagaya F, Suzuki Y, Joukou S: Stevens-Johnson syndrome induced by methazolamide treatment. Arch. Ophthalmol. 115(4), 550-553 (1997).
3. Roujeau JC, Stern RS: Severe adverse cutaneous reactions to drugs. N. Engl. J. Med. 331(19), 1272-1285 (1994).
4. Cotter JB: Methazolamide-induced Stevens-Johnson syndrome: a warning! Arch. Ophthalmol. 116(1), 117 (1998).
5. Park YJ, Moon JI, Park CK: Three cases of Stevens-Johnson syndrome associated with methazolamide treatment. J. Korean Ophthalmol. Soc. 40(2), 613-618 (1999).
6. Moon JI, Seo JH, Park CK: Association of HLA type with Stevens-Johnson syndrome induced by methazolamide treatment. J. Korean Ophthalmol. Soc. 41(10), 2241-2246 (2000).
7. Ahn EY, Lee JB, Lee SC, Won YH: Four cases of Stevens-Johnson syndrome associated with methazolamide treatment. Korean Dermatol. 38(6), 798-801 (2000).
8. Sung KH, Jwong Y, Choi HU, Lee SK: Two cases of HLA-B59(+) Stevens-Johnson syndrome (SJS)-toxic epidermal necrolysis (TEN) associated with methazolamide treatment. Korean Dermatol. 43(4), 561-563 (2005).
9. Lee KW, Oh HD, Lee C, Yang SY: Allelic and haplotypic diversity of HLA-A,-B,-C,-DRB1, and-DQB1 genes in the Korean population. Tissue Antigens 65(5), 437-447 (2005).
10. Saito S, Ota S, Yamada E, Inoko H, Ota M: Allele frequencies and haplotypic associations defned by allelic DNA typing at HLA class I and class II loci in the Japanese population. Tissue Antigens 56(6), 522-529 (2000).
11. Roujeau JC: The spectrum of Stevens-Johnson syndrome and toxic epidermal necrolysis: a clinical classifcation. J. Invest. Dermatol. 102(6), S28-S30 (1994).
12. Seo YS, Chang KC, Chang MH: Methazolamide-induced Stevens-Johnson Syndrome. J. Korean Ophthalmol. Soc. 50(12), 1881-1886 (2009).
13. Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16(3), 1215 (1988).
14. French LE: Toxic epidermal necrolysis and Stevens-Johnson syndrome: our current understanding. Allergol. Int. 55(1), 9-16 (2006).
15. Borchers AT, Lee JL, Naguwa SM, Cheema GS, Gershwin ME: Stevens-Johnson syndrome and toxic epidermal necrolysis. Autoimmun. Rev. 7(8), 598-605 (2008).
16. Pirmohamed M: Genetic factors in the predisposition to drug-induced hypersensitivity reactions. AAPS J. 8(1), E20-E26 (2006).
17. Chung WH, Hung SI, Chen YT: Human leukocyte antigens and drug hypersensitivity. Curr. Opin. Allergy Clin. Immunol. 7(4), 317-323 (2007).
18. Sheffeld LJ, Phillimore HE: Clinical use of pharmacogenomic tests in 2009. Clin. Biochem. Rev. 30(2), 55-65 (2009).
19. Chung WH, Hung SI, Hong HS et al.: A marker for Stevens-Johnson syndrome. Nature 428(6982), 486 (2004).
20. Alfrevic A, Jorgensen AL, Williamson PR, Chadwick DW, Park BK, Pirmohamed M: HLA-B locus in Caucasian patients with carbamazepine hypersensitivity. Pharmacogenomics 7(6), 813-818 (2006).
21. Kaniwa N, Saito Y, Aihara M et al.: HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis. Pharmacogenomics 9(11), 1617-1622 (2008).
22. Lee JH, Lee SJ, Kim YH: A case of Stevens-Johnson syndrome after acetazolamide use. J. Korean Ophthalmol. Soc. 39(1), 216-220 (1998).
23. Ha JH, Song JY, Kim HO, Kim JW: A case of Stevens-Johnson syndrome caused by acetazolamide. Korean J. Dermatol. 41(2), 248-250 (2003).
24. Kim J W, Shin SY: Toxic epidermal necrolysis and Stevens-Johnson syndrome caused by topical ophthalmic use of dorzolamide. Korean J. Dermatol. 47(3), 317-321 (2009).
25. Chun JS, Yun SJ, Lee JB, Kim SJ, Won YH, Lee SC: Toxic epidermal necrolysis induced by the topical carbonic anhydrase inhibitors brinzolamide and dorzolamide. Ann. Dermatol. 20(4), 260-262 (2008).
26. Roujeau JC, Huynh TN, Bracq C, Guillaume JC, Revuz J, Touraine R. Genetic susceptibility to toxic epidermal necrolysis. Arch. Dermatol. 123(9), 1171-1173 (1987). (Pubitemid 17119310)
27. Lonjou C, Borot N, Sekula P et al.: A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to fve high-risk drugs. Pharmacogenet. Genomics. 18(2), 99-107 (2008).
28. Slatore CG, Tilles SA: Sulfonamide hypersensitivity. Immunol. Allergy Clin. North Am. 24(3), 477-490 (2004).
29. Brackett CC, Singh H, Block JH: Likelihood and mechanisms of crossallergenicity between sulfonamide antibiotics and other drugs containing a sulfonamide functional group. Pharmacotherapy 24(7), 856-870 (2004).
30. Monnet D, Brézin AP: Birdshot chorioretinopathy. Curr. Opin. Ophthalmol. 17(6), 545-550 (2006).
31. Martin TM, Kurz DE, Rosenbaum JT: Genetics of uveitis. Ophthalmol. Clin. North Am. 16(4), 555-565 (2003).